Increase in emergency admissions to hospital for children aged under 15 in England, 1999-2010: national database

Peter J Gill1, Michael J Goldacre, David Mant

  • 1Department of Primary Care Health Sciences, University of Oxford, Oxford OX2 6GG, UK. peter.gill@phc.ox.ac.uk

Insights

Emergency hospital admissions for children in England rose by 28% from 1999 to 2010. This increase, particularly for common infections, suggests potential failures in community and hospital care delivery for pediatric patients.

Area of Science:

  • Pediatric healthcare utilization
  • Public health trends
  • Healthcare system analysis

Background:

  • Emergency hospital admissions for children in England have shown a notable increase.
  • Conditions typically managed in community settings are increasingly leading to hospitalizations.

Purpose of the Study:

  • To investigate the rise in emergency hospital admissions for children in England.
  • To analyze trends for conditions usually managed in primary care.

Main Methods:

  • A population-based study analyzing Hospital Episode Statistics and population estimates for children under 15 in England.
  • Data covers the period from 1999 to 2010.

Main Results:

  • The emergency admission rate for children under 15 increased by 28% (63 to 81 per 1000 population) between 1999 and 2010.
  • Short-term admissions (<1 day) doubled, offsetting a decline in longer admissions.
  • Admissions for common infections like respiratory and urinary tract infections, and gastroenteritis, rose significantly (22-43%).

Conclusions:

  • The rise in short-stay admissions for common childhood infections indicates potential systemic failures in primary and hospital care.
  • There is a need to reassess the assessment and management of acute pediatric illnesses within community and emergency settings.
  • Restructuring acute pediatric care delivery is likely necessary to address these trends.
Abstract

Related Concept Videos

Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...